Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Chia-Yi, Taiwan, ROC.
Prostate. 2013 Mar;73(4):391-7. doi: 10.1002/pros.22580. Epub 2012 Sep 13.
The mechanism of non-bacterial chronic prostatitis (CP/CPPS) has long been investigated but remains unclear. Under the hypothesis that abnormal response of innate immunity may be a cause of CP/CPPS, this study evaluated inflammasome, as part of innate immunity, and its effects on persist inflammation and CP/CPPS.
Carrageenan was used to induce CP/CPPS in a rat animal model. After confirming tactile hyper-algesia in the rats, their local prostate inflammation status, and inflammasome expression were determined. The amount of inflammasome and its downstream protein was checked, along with prostate localization. Chlorogenic acid (CHA), an active ingredient of Chinese herbal remedy for CP/CPPS treatment, was used as treatment.
The rats had CP/CPPS once scrotal static tactile allodynia developed and CHA treatment relieved the scrotal hypersensitivity. Downstream inflammasome proteins like IL-1β and caspase 1 increased within the prostate and decreased with CHA treatment. Inflammasome, NALP1 but not NALP3, was significantly increased in the prostate glandular endothelial cells. Treatment with CHA also changed the distribution pattern of NALP1 in the prostate.
There is a close relationship between activation of inflammasome and patho-physiologic changes of CP/CPSS in rats. Increased inflammasome may be a possible mechanism of CP/CPPS and clinically active regimen may inhibit the inflammasome-related pathway. This provides a new therapeutic rationale and approach for CP/CPPS treatment.
非细菌性慢性前列腺炎(CP/CPPS)的发病机制长期以来一直受到研究,但仍不清楚。在先天免疫异常反应可能是 CP/CPPS 病因的假说下,本研究评估了作为先天免疫一部分的炎症小体及其对持续炎症和 CP/CPPS 的影响。
在大鼠动物模型中使用角叉菜胶诱导 CP/CPPS。在确认大鼠出现触觉超敏反应后,确定其局部前列腺炎症状态和炎症小体表达。检查炎症小体及其下游蛋白的数量以及前列腺定位。绿原酸(CHA)是治疗 CP/CPPS 的中药的有效成分,用作治疗药物。
一旦大鼠出现阴囊静态触觉过敏,就会发生 CP/CPPS,而 CHA 治疗可缓解阴囊过敏。前列腺内的下游炎症小体蛋白(如 IL-1β和 caspase 1)增加,而 CHA 治疗后则减少。前列腺腺泡内皮细胞中炎症小体 NALP1 而非 NALP3 明显增加。CHA 治疗还改变了前列腺中 NALP1 的分布模式。
在大鼠中,炎症小体的激活与 CP/CPSS 的病理生理变化密切相关。炎症小体的增加可能是 CP/CPPS 的一种可能机制,而临床有效的方案可能会抑制炎症小体相关途径。这为 CP/CPPS 的治疗提供了新的治疗依据和方法。